The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

Irritable bowel syndrome (IBS) is a common disorder in gastrointestinal system and impairs the quality of life of the patients. Clostridium butyricum (CB) is a probiotics that has been used in several gastrointestinal diseases. The efficacy of CB in treating IBS is still unknown. This prospective, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yi-Yuan, Li, Ming, Li, Yue-Yue, Li, Li-Xiang, Zhai, Wen-Zhe, Wang, Peng, Yang, Xiao-Xiao, Gu, Xiang, Song, Li-Jin, Li, Zhen, Zuo, Xiu-Li, Li, Yan-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813237/
https://www.ncbi.nlm.nih.gov/pubmed/29445178
http://dx.doi.org/10.1038/s41598-018-21241-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813237/
https://www.ncbi.nlm.nih.gov/pubmed/29445178
http://dx.doi.org/10.1038/s41598-018-21241-z

Ejemplares similares